Weblocal.ca Mobile

Transition Therapeutics

101 College St
Toronto, ON M5G 1L7

(416) 260-7770

Rating: Unrated
Get directions starting from
BioTech Business/Industry


Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition’s lead products include ELND005 for the treatment of Alzheimer’s disease and TT223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally and developed internally using its proprietary drug discovery engine.
by crunchbase on July 03, 2013 from crunchbase

Search for in Open Now

Are you the business owner?
Privacy Policy | Terms of Use | HTML Site